Page last updated: 2024-08-17

aldosterone and anacetrapib

aldosterone has been researched along with anacetrapib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hegele, RA; Joy, TR1
Bloomfield, D; Briscoe, RJ; Brown, PN; Cumiskey, AM; Ehrhart, J; Forrest, MJ; Hershey, JC; Keller, WJ; Ma, X; McPherson, HE; Messina, E; Peterson, LB; Sharif-Rodriguez, W; Siegl, PK; Sinclair, PJ; Sparrow, CP; Stevenson, AS; Sun, SY; Tsai, C; Vargas, H; Walker, M; West, SH; White, V; Woltmann, RF1
Stroes, ES; Vergeer, M1
Even, S; Montezano, AC; Neves, KB; Nguyen Dinh Cat, A; Palacios, R; Rios, FJ; Touyz, RM1
Ready, JM1

Reviews

1 review(s) available for aldosterone and anacetrapib

ArticleYear
The pharmacology and off-target effects of some cholesterol ester transfer protein inhibitors.
    The American journal of cardiology, 2009, Nov-16, Volume: 104, Issue:10 Suppl

    Topics: Aldosterone; Amides; Animals; Anticholesteremic Agents; Atherosclerosis; Blood Pressure; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Corticosterone; Esters; Humans; Hydrocortisone; Hypercholesterolemia; Oxazolidinones; Quinolines; Sulfhydryl Compounds

2009

Other Studies

4 other study(ies) available for aldosterone and anacetrapib

ArticleYear
The failure of torcetrapib: what have we learned?
    British journal of pharmacology, 2008, Volume: 154, Issue:7

    Topics: Aldosterone; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Oxazolidinones; Quinolines

2008
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.
    British journal of pharmacology, 2008, Volume: 154, Issue:7

    Topics: Adrenal Cortex; Aldosterone; Animals; Anticholesteremic Agents; Blood Pressure; Cholesterol Ester Transfer Proteins; Corticosterone; Dogs; Drug Evaluation, Preclinical; Female; Macaca mulatta; Male; Mice; Mice, Inbred C57BL; Models, Animal; Muscle, Smooth, Vascular; Oxazolidinones; Quinolines; Rats; Rats, Sprague-Dawley; Species Specificity

2008
Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 353, Issue:1

    Topics: Adipocytes; Aldosterone; Amides; Animals; Cell Line; Cholesterol Ester Transfer Proteins; Esters; Humans; Mice; NADPH Oxidases; Oxazolidinones; Phosphorylation; Quinolines; Reactive Oxygen Species; STAT3 Transcription Factor; Sulfhydryl Compounds

2015
Toward a Best-in-Class Inhibitor of Cholesteryl Ester Transfer Protein (CETP).
    Journal of medicinal chemistry, 2021, 09-23, Volume: 64, Issue:18

    Topics: Aldosterone; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Drug Development; Humans; Mice, Transgenic; Molecular Structure; Oxazolidinones

2021
chemdatabank.com